Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
15 Cards in this Set
- Front
- Back
when is xrt therapy required after mastectomy?
|
Tumors greater than 5 cm
Positive surgical margins 4 or more positive axillary lymph nodes |
|
when do you use CMF in BC?
|
in low risk or intermed risk
node neg disease only >1 cm |
|
when do you use antracycline countaining regimen in BC?
|
node+ w/wo taxane
High risk N- disease HER2+ ER- |
|
taxane containing regimens in BC?
|
node-positive disease
|
|
Triple neg BC
|
benefit from neoadv
a+-taxane in lymph node + followed by surgery |
|
management of operational III BC
|
just large tumor N1
surgery +- radio |
|
stage III a,b,c bc tx
no response? |
neoadv chemo
if response then local therapy - may be surgery - RADIO and Remove axillary nodes no response= chemo considered, neo adv surgery |
|
T4c inflammatory BC bc
|
clinical trials
ex: ER- HER2 + consider neoadv taxane |
|
when do you use fulvestrant?
|
when tamoifen has failed inrecurrnace
after stable disease after amoratase inhib |
|
mammogram screening specificity
|
number of patients with a negative test who do not have the disease/number of patients who do not have the disease
|
|
mammogram screening sensivity
|
Patients with a positive mammogram/all patients screened with a mammogram who have breast cancer
|
|
most important prognostic factor in BC?
|
axillary lymph node status
|
|
chemo in ovarian cancer?
|
taxane and cispaltin
|
|
type I uterine tumor
|
adenocarcinoma
low grade stim by estrogen |
|
type II uterine tumor
|
papillary or clear cell
high grade unrelated to estrogen more aggressive! |